CClinicalTrials.gg
Status unknownNCT02645708Updated Feb 15, 2017

External Physical Vibration Lithecbole(EPVL) Versus Traditional Row of Stone After Retrograde Intrarenal Surgery(RIRS)

An interventional study of Retrograde Intrarenal Surgery and EPVL after RIRS in Renal Calculi, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Status unknown at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-02-15.

Sponsored by The First Affiliated Hospital of Guangzhou Medical University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The treatment of renal calculus by retrograde intrarenal surgery(RIRS) isn't able to eliminate stone completely, hastening fragments clearance just only rely on traditional expulsive methods such as high fluid intake ,increasing physical activity, medical expulsive therapy and changing body position. Therefore, researchers purpose to evaluate the effectiveness of external physical vibration lithecbole(EPVL) in treatment of residual fragments after RIRS by prospective study of clinical trial, which will improve stone-free rate of residual fragments and benefit more patients.

Read the detailed description

To evaluate the efficacy and safety of external physical vibration lithecbole for the treatment of residual stone after the operation of RIRS,thereby improving stone clearance rate. Investigators will do a multi-centers randomized controlled trial(RCT),and investigators plan to perform this study in 10 hospitals,which are the First Affiliated Hospital of Guangzhou Medical University of China, Department of Urology, The Second Affiliated Hospital of Zhengzhou University of China, Jiangsu Province Hospital, Hubei Province Hospital, Zhongshan Hospital, Tongji Hospital,Hubei provincial people's Hospital,Guilin 181 Hospital,the People' Hospital of Huzhou,The People' Hospital of Shaoyang.

Investigators plan to beginning their study August 2015 and end July 2016. One hundred and eighty patients with postoperative residual stone after RIRS will be enrolled in this study. By simple random sampling technique, all the patients will be assigned to the segment of natural stone row group or physical row of stone group, compared two groups of patients with stone clearance rate and complications, Investigators hope that through this test, improve stone clearance rate after RIRS.

The principle of extracorporeal physical vibration:

A Simple harmonic motion technology in multi-direction was applied. The Lateral acceleration was provided by the physical vibration device in the base through the harmonic vibration wave in the horizontal direction, which induces the urinary stone separate with the kidney or ureter, and expands a moving space for the stone. Meanwhile, an axial effect was produced to push the stone by the physical vibration device in the handle through the harmonic vibration wave in the multi- direction. Finally, with the help of changing the position and direction of the extracorporeally physical vibration machine, the urinary stone was discharged from the urinary collecting system.

Number:

180cases(90 cases in control group, 90 cases in EPVL group)

Grouping methods:

In this trial, investigators use equilibrium randomization methods that generate random numerical code table, according to the table, patients are randomly assigned to different groups.

Evaluating indicator Stone-free rate in 5 weeks after RIRS. Incidence rate of complications and adverse reactions after EPVL(fever, hematuria).

Trial method; Cases selection and grouping: in 1 week after RIRS, the imaging KUB(abdominal plain film), patients with radiolucent calculus need to be examined by CT demonstrate the presence of residual fragments, and the cases that meeting inclusion criterion are randomly assigned to groups, and the ureteral stent should be removed in 2 weeks;

Laboratory testing: blood routine, urine routine, renal function , coagulation function; Strat the treatment of EPVL before the removal of ureteral stent.

Methods of control group(group1):

RIRS without EPVL Patients should be reexamined respectively in 1 and 2 weeks after RIRS, and the ureteral stent should be removed in 2 weeks;

Patients should follow the measures below:

  1. the amount of fluid intake is more than 2000ml/d
  2. increase physical activity
  3. rest in position on uninjured side, patients with lower renal calyx calculus need to invert body;

Follow up timing: respectively in 2 ,3 and 5 weeks after RIRS.

Methods of EPVL group(group2):

Preparation before EPVL: the amount of fluid intake is about 1000-2000ml, start the treatment of EPVL when patient's bladder is filling;

Record: patients' information, outcome of treatment (examined by KUB right after EPVL); Start the treatment of EPVL;

Patients should follow the measures below:

  1. the amount of fluid intake is more than 2000ml/d
  2. increase physical activity
  3. rest in position on uninjured side, patients with lower renal calyx calculus need to invert body;

Patients should be reexamined in one week, meanwhile removing ureteral stent or perhaps undergoing the treatment of EPVL once again.

Follow up timing: respectively in 1,2 and 4 weeks after EPVL..

Follow up project Laboratory testing: routine urinalysis; Imaging examination: KUB or kidney CT scan (radiolucent calculus) Complications and adverse reactions. Data gathering Fill in follow up table data; Radiological images; IVP(intravenous pyelography) or kidney CT scan; Reexamined by KUB (radiopaque calculus) or CT (radiolucent calculus) right after RIRS, respectively in 2 ,3 and 5 weeks after RIRS. If stones have been eliminated completely in patients with radiolucent calculus before or at the fourth week of follow-up, investigator must provide kidney CT scan.

02

Conditions studied

  • Renal Calculi

Keywords

  • RIRS
  • EPVL
  • PDI(Percussion,Diuresis,Inversion)
  • Randomized Controlled Trial
03

In context

Kidney Calculi

598 studies on the registry are indexed under Kidney Calculi; 163 are open to participants now.

This study's planned enrollment of 180 is above the median of 90 across 461 interventional studies indexed under Kidney Calculi.

Browse Kidney Calculi studies →

Lead sponsor

The First Affiliated Hospital of Guangzhou Medical University is the lead sponsor of 158 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age of 18-65 years;
  2. The imaging demonstrate the presence of residual fragments in 1 week after RIRS;
  3. Renal or upper ureteral calculus;
  4. There's no urinary tract obstruction below stones, and stones didn't cause complete urinary tract obstruction;
  5. Stones are fragmented successfully on single session of RIRS, and the diameter of any of fragments is less than 4mm;
  6. Normal renal function.

Exclusion criteria

Exclusion Criteria:

  1. Couldn't tolerate EPVL;
  2. Urinary tract anomalies, stricture or obstruction;
  3. Calculus in diverticulum;
  4. Severe hydronephrosis;
  5. Combined with acute urinary tract infection;
  6. Coagulation abnormalities;
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Other
    Retrograde Intrarenal Surgery (RIRS)

    Patients in Group 1 undergo Retrograde Intrarenal Surgery

    Procedure: Retrograde Intrarenal Surgery

  • Other
    EPVL after RIRS

    Patients in Group 2 undergo external physical vibration lithecbole after Retrograde Intrarenal Surgery. with the help of changing the position and direction of the extracorporeally physical vibration machine, the urinary stone was discharged from the urinary collecting system

    Procedure: EPVL after RIRS

Interventions

  • ProcedureRetrograde Intrarenal Surgery

    Patients undergo Retrograde Intrarenal Surgery

  • ProcedureEPVL after RIRS

    Patients in Group 2 undergo EPVL after RIRS

06

What researchers measure

Primary outcomes

  1. Change from stone free rate(SFR) with different follow-up periods

    Primary SFR is assessed by abdominal plain film (KUB)at2,3,5 week after operation. Stone-free status are defined as either the absence of any residual stone fragments.

    Time frame: return hospital respectively in 2,3 and 5 week after RIRS

Secondary outcomes

  1. extracorporeal physical vibration complications

    Complication is defined as any adverse event occurred

    Time frame: return hospital respectively in 2 ,3 and 5 weeks after RIRS

07

Study locations

1 of 1 sites recruiting
  • Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong 510230, China
    • Guohua Zeng, Ph.D and M.D · Contact · gzgyzgh@vip.tom.com · +86 13802916676
    • Guohua Zeng, Ph.D and M.D · Principal investigator
    • Zhou Yang · Sub investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02645708
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Responsible party
Guohua Zeng (Vice President of the Hospital, The First Affiliated Hospital of Guangzhou Medical University) — Principal investigator
First posted
Jan 5, 2016
Start date
Aug 2015
Primary completion
Mar 2017 (estimated)
Completion
Mar 2017 (estimated)
Last update
Feb 15, 2017

Study contacts

Guohua Zeng, PH.D and M.D
Contact
gzgyzgh@vip.tom.com
+86 13802916676
Zhou Yang
Contact
910074460@qq.com
+86 13416129917
Guohua Zeng, PH.D and M.D
study chair · The First Affiliated Hospital of Guangzhou Medical

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion